Waisman Biomanufacturing partners with GigaGen to manufacture new COVID-19 drug
Read the full press release here Waisman Biomanufacturing at the University of Wisconsin–Madison will begin manufacturing a new drug to treat and prevent COVID-19, developed by California-based biotech company GigaGen. The drug, called GIGA-2050, uses a new approach similar to…